Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
E Jude
Observed names:
E. Jude,
E. Okokon Jude .,
Evon Jude
Institutions:
Western Health,
Olivia Newton-John Cancer Wellness & Research Centre,
Austin Health,
Olivia Newton-John Cancer Research Institute
Observed institutions:
Austin Hospital,
Western Health,
Olivia Newton-John Cancer Wellness & Research Centre,
Austin Health,
Olivia Newton-John Cancer Research Institute
ORCID:
0009-0008-5994-4547
Observed ORCID:
0009-0008-5994-4547
OpenAlex ID:
A5110612363
Antiplasmodial Activity of Ethanolic Root Extract of Telfairia occidentalis
2007
·
E. Okokon Jude .
, J. Ekpo Arit .
, et al.
·
Research Journal of Parasitology
·
19
Prognostic significance of absolute lymphocyte count in patients with metastatic renal cell carcinoma receiving first-line combination immunotherapies: results from the International Metastatic Renal Cell Carcinoma Database Consortium
2024
·
K. Takemura
, T. Yuasa
, et al.
·
ESMO Open
·
11
PDF
Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma
2024
·
Justine Panian
, Caiwei Zhong
, et al.
·
European Urology Focus
·
7
Antimalarial activities of Breynia Nivosa
2015
·
E Jude
, Davis Koofreh
, et al.
·
Journal of Herbal Drugs: International Journal on Medicinal Herbs
·
5
Real‐World Toxicity and Outcomes of KEYNOTE‐522‐Style Neoadjuvant Pembrolizumab for Triple‐Negative Breast Cancer in Australia
2026
·
Evon Jude
, Sarah Jaboury
, et al.
·
Asia-Pacific Journal of Clinical Oncology
PDF
Real‐world outcomes in patients with hormone receptor positive, human epidermal growth factor receptor 2 receptor‐negative advanced breast cancer and visceral metastases at baseline – advanced hormone receptor positive breast cancer registry in Australia
2026
·
Lucas Wigston
, Ali Morris
, et al.
·
Internal Medicine Journal
35 Efficacy of treatments post-lenvatinib in patients with advanced renal cell carcinoma (aRCC)
2024
·
Justine Panian
, Caiwei Zhong
, et al.
·
The Oncologist
PDF
233P Real-world first-line (1L) treatment selection for Australian patients (pts) with hormone receptor-positive advanced breast cancer (HR+ ABC)
2024
·
V. Wong
, S.E. Baron-Hay
, et al.
·
ESMO Open
PDF
In Vivo Antimalarial Activity of Ethanolic Leaf Extract Ofacacia Auriculiformis
2010
·
Okokon
, E Jude
, et al.
·
International Journal of Drug Development and Research
Show more works
View as search
Works count:
9
Citation count:
42
H-index:
4
I10-index:
2
Year
Topic
Type